These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34568014)

  • 1. Apigenin Inhibits the Histamine-Induced Proliferation of Ovarian Cancer Cells by Downregulating ERα/ERβ Expression.
    Liu M; Zhang Y; Xu Q; Liu G; Sun N; Che H; He T
    Front Oncol; 2021; 11():682917. PubMed ID: 34568014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apigenin Inhibits Histamine-Induced Cervical Cancer Tumor Growth by Regulating Estrogen Receptor Expression.
    Zhang E; Zhang Y; Fan Z; Cheng L; Han S; Che H
    Molecules; 2020 Apr; 25(8):. PubMed ID: 32340124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression and correlation between the transcription factor FOXP1 and estrogen receptors in epithelial ovarian cancer.
    Hu Z; Zhu L; Tan M; Cai M; Deng L; Yu G; Liu D; Liu J; Lin B
    Biochimie; 2015 Feb; 109():42-8. PubMed ID: 25500588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apigenin inhibits antiestrogen-resistant breast cancer cell growth through estrogen receptor-alpha-dependent and estrogen receptor-alpha-independent mechanisms.
    Long X; Fan M; Bigsby RM; Nephew KP
    Mol Cancer Ther; 2008 Jul; 7(7):2096-108. PubMed ID: 18645020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated estrogen receptor β expression in triple negative breast cancer cells is associated with sensitivity to doxorubicin by inhibiting the PI3K/AKT/mTOR signaling pathway.
    Lei S; Fan P; Wang M; Zhang C; Jiang Y; Huang S; Fang M; He Z; Wu A
    Exp Ther Med; 2020 Aug; 20(2):1630-1636. PubMed ID: 32742395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apigenin inhibits cell proliferation, migration, and invasion by targeting Akt in the A549 human lung cancer cell line.
    Zhou Z; Tang M; Liu Y; Zhang Z; Lu R; Lu J
    Anticancer Drugs; 2017 Apr; 28(4):446-456. PubMed ID: 28125432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic utility of natural estrogen receptor beta agonists on ovarian cancer.
    Liu J; Viswanadhapalli S; Garcia L; Zhou M; Nair BC; Kost E; Rao Tekmal R; Li R; Rao MK; Curiel T; Vadlamudi RK; Sareddy GR
    Oncotarget; 2017 Jul; 8(30):50002-50014. PubMed ID: 28654894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of estrogen receptor mediates migration, invasion and proliferation of endometrial carcinoma cells by regulating the PI3K/AKT/mTOR pathway.
    Hou X; Zhao M; Wang T; Zhang G
    Oncol Rep; 2014 Mar; 31(3):1175-82. PubMed ID: 24366110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen-independent role of ERα in ovarian cancer progression induced by leptin/Ob-Rb axis.
    Ghasemi A; Saeidi J; Mohtashami M; Hashemy SI
    Mol Cell Biochem; 2019 Aug; 458(1-2):207-217. PubMed ID: 31077012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of estrogen in lung cancer based on the estrogen receptor-epithelial mesenchymal transduction signaling pathways.
    Zhao XZ; Liu Y; Zhou LJ; Wang ZQ; Wu ZH; Yang XY
    Onco Targets Ther; 2015; 8():2849-63. PubMed ID: 26491358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of estrogen receptor subtypes and variants in ovarian cancer: effects on cell invasion, proliferation and prognosis.
    Chan KKL; Siu MKY; Jiang YX; Wang JJ; Wang Y; Leung THY; Liu SS; Cheung ANY; Ngan HYS
    BMC Cancer; 2017 Aug; 17(1):606. PubMed ID: 28859612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of estrogen receptor beta in ovarian carcinogenesis.
    Bardin A; Hoffmann P; Boulle N; Katsaros D; Vignon F; Pujol P; Lazennec G
    Cancer Res; 2004 Aug; 64(16):5861-9. PubMed ID: 15313930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of stable reporter breast cancer cell lines for the identification of ER subtype selective ligands.
    Shanle EK; Hawse JR; Xu W
    Biochem Pharmacol; 2011 Dec; 82(12):1940-9. PubMed ID: 21924251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative regulation of estrogen signaling by ERβ and RIP140 in ovarian cancer cells.
    Docquier A; Garcia A; Savatier J; Boulahtouf A; Bonnet S; Bellet V; Busson M; Margeat E; Jalaguier S; Royer C; Balaguer P; Cavaillès V
    Mol Endocrinol; 2013 Sep; 27(9):1429-41. PubMed ID: 23885094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting estrogen receptor subtypes (ERα and ERβ) with selective ER modulators in ovarian cancer.
    Chan KK; Leung TH; Chan DW; Wei N; Lau GT; Liu SS; Siu MK; Ngan HY
    J Endocrinol; 2014 May; 221(2):325-36. PubMed ID: 24819599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells.
    Williams C; Edvardsson K; Lewandowski SA; Ström A; Gustafsson JA
    Oncogene; 2008 Feb; 27(7):1019-32. PubMed ID: 17700529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of estrogen receptor α and β in the regulation of proliferation in endometrial carcinoma.
    Hu G; Zhang J; Zhou X; Liu J; Wang Q; Zhang B
    Pathol Res Pract; 2020 Oct; 216(10):153149. PubMed ID: 32853964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of estrogen receptor β agonists on proliferation and gene expression of ovarian cancer cells.
    Schüler-Toprak S; Moehle C; Skrzypczak M; Ortmann O; Treeck O
    BMC Cancer; 2017 May; 17(1):319. PubMed ID: 28482871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PES1 differentially regulates the expression of ERα and ERβ in ovarian cancer.
    Li J; Zhuang Q; Lan X; Zeng G; Jiang X; Huang Z
    IUBMB Life; 2013 Dec; 65(12):1017-25. PubMed ID: 24376209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.